Pre-Emptive Rituximab Treatment for Epstein-Barr Virus (EBV) Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): High Incidence of Infections and Delayed Immune Reconstitution

被引：0
|
作者：
Petropoulou, Anna D. [1 ]
Porcher, Raphael [1 ]
de Latour, Regis Peffault [1 ]
Xhaard, Alienor [1 ]
Ribaud, Patricia [1 ]
Socie, Gerard [1 ]
Robin, Marie [1 ]
机构：
[1] St Louis Hosp, Paris, France
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：950 / 951
页数：2
相关论文
共 50 条
  • [31] Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes
    Ru, Yuhua
    Zhang, Xiang
    Song, Tiemei
    Ding, Yiyang
    Zhu, Ziling
    Fan, Yi
    Xu, Yang
    Sun, Aining
    Qiu, Huiying
    Jin, Zhengming
    Tang, Xiaowen
    Han, Yue
    Fu, Zhengzheng
    Chen, Suning
    Ma, Xiao
    Chen, Feng
    Chen, Jia
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1754 - 1762
  • [32] Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation:: Relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
    Clave, E
    Agbalika, F
    Bajzik, V
    de Latour, RP
    Trillard, M
    Rabian, C
    Scieux, C
    Devergie, A
    Socié, G
    Ribaud, P
    Adès, L
    Ferry, C
    Gluckman, E
    Charron, D
    Esperou, H
    Toubert, A
    Moins-Teisserenc, H
    TRANSPLANTATION, 2004, 77 (01) : 76 - 84
  • [33] Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem cell transplantation
    Ahmad, Imran
    Kwan, John
    Meuleman, Nathalie
    Lewalle, Philippe
    Crokaert, Francoise
    Bron, Dominique
    BLOOD, 2007, 110 (11) : 328B - 328B
  • [34] Rituximab as pre-emptive therapy for EBV-reactivation following T-cell depleted allogeneic stem cell transplantation
    Peccatori, J
    Stanghellini, ML
    Bernardi, M
    Ruggeri, A
    Calbi, V
    Servida, P
    Rolla, S
    Racca, S
    Dominietto, A
    Tedone, E
    Soracco, M
    Bregni, M
    Ciceri, F
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S165 - S165
  • [35] Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
    Carpenter, Ben
    Haque, Tanzina
    Dimopoulou, Maria
    Atkinson, Claire
    Roughton, Michael
    Grace, Sarah
    Denovan, Shari
    Fielding, Adele
    Kottaridis, Panagiotis D.
    Griffiths, Paul
    Mackinnon, Stephen
    Emery, Vincent
    Chakraverty, Ronjon
    TRANSPLANTATION, 2010, 90 (05) : 564 - 570
  • [36] Valganciclovir is safe and effective as pre-emptive treatment for CMV reactivation in allogeneic hematopoietic stem cell transplantation
    Pastano, R.
    Gigli, F.
    Andreola, G.
    Peccatori, F. A.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 468 - 468
  • [37] Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab
    Wei, Na
    Wang, Yini
    Wang, Jingshi
    Wu, Lin
    Wang, Zhao
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1449 - 1451
  • [38] Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation.
    Peric, Zinaida
    Cahu, Xavier
    Chevallier, Patrice
    Brissot, Eolia
    Malard, Florent
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Le Gouill, Steven
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harrouseau, Jean-Luc
    Moreau, Philippe
    Milpied, Noel
    Coste-Burel, Marianne
    Imbert-Marcille, Berthe-Marie
    Mohty, Mohamad
    BLOOD, 2010, 116 (21) : 539 - 540
  • [39] Incidence and Impact of Epstein-barr Virus Events in the Early Phase after Allogeneic Hematopoietic Stem Cell Transplantation
    Macy, Samuel
    Khanna, Nina
    Hirsch, Hans
    Heim, Dominik
    Lengerke, Claudia
    Tsakiris, Dimitrios
    Passweg, Jakob
    Medinger, Michael
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 485 - 485
  • [40] Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
    Kaya, Nazli Nida
    Kupeli, Serhan
    Ozturk, Gokhan
    Bayram, Ibrahim
    Ozdogru Sagdic, Deniz
    Sezgin, Gulay
    Koksal, Fatih
    Yarkin, Fugen
    FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2018, 23 (01): : 15 - 24
12345